Cardiovascular diseases (CVDs), which involve heart conditions and stroke and rank as one of the most widespread and resilient health problems globally, pose a big dilemma for the healthcare industry and require constant rescaling and enhancement of care protocols. In this regard, the issue of the successful handling of patients with CVDs arises, which is necessary to reduce the undesirable consequences and ensure a complete wellness regimen. This essay delves into the care given to certain sub-groups of cardiovascular patients within our local healthcare approach to determine the need. In this context, the essay primarily focuses on an in-depth analysis that highlights the shortcomings of courteous care while closely examining areas with significant potential for improvement and new innovation. Using judicious integration of nationwide and international norms along with the latest advancements in the field of research, this discourse will challenge the current model of care provision and point out opportunities for innovative care delivery to maximize efficacy and improve professional performance. On a more general level, this paper presents the role of critical scrutiny in reshaping the cardiovascular healthcare system to align with the defined goals within the module.
In this article, I will emphasize the significance of providing customized care to patients with coronary artery disease (CAD) within the current healthcare environment in our country. CAD is the most common heart disease, the development of which is characterized by the gradual change or obstruction of arteries by atherosclerosis, which leads to a range of serious problems like angina pectoris, myocardial infarction, and heart failure (Zhu & Cheng, 2021, 641). The very magnitude and multifaceted nature of CAD point to its standing as the axis in the cardiovascular health domain; therefore, a stepped-up and holistic strategy for its care is vital.
When deciding on the best approach for CAD management, a comprehensive understanding of the epidemiological setting is an absolute necessity in order to make a thoughtful evaluation of care delivery. Epidemiological data act as a basis for context, as the data is able to describe the occurrence, the increments, and the distribution of CAD within our community. Specifically, the examination of demographic trends presents a better picture of the age groups most affected by CAD, hence prioritizing them for select intervention programs and resource allocation strategies (Xu et al., 2022, 614). The two important things are a general appreciation of the varied symptomatic manifestations and clinical implementation caused by CAD, which may range from subtle exertional chest discomfort to catastrophic myocardial infarctions and cardiac decompensation. Furthermore, a dimensional comprehension of the prolonged grave effects the disease has on the social welfare of individuals demonstrates the necessity of an effective health care delivery system that will assist patients to live better and reduce healthcare costs for society (Zeymer et al., 2020, 185). As a result, this assessment within the context of CAD’s unique epidemiology, demographics, symptoms, and consequences covers a spectrum of comprehensive and acute analysis of the system.
The examination of the care delivery to CAD patients in our local area urges us to look into details, from a thorough examination and review of current literature and research articles to identifying flaws and possible interventions. The first phase of the process, which aims at understanding the current care practice and whether it fits well with the reference documents and evidence-based care, is fundamental (Wyckoff et al., 2021, 721). This evaluative process employs the close scrutiny of a range of sites, including national, local, and international sources of advanced scholarship. By comparing and contrasting the obtained information, the process aims to discern patterns, developments, and disparities in administrative, clinical, and support processes (Chui et al., 2020, 23). A thorough analysis reveals the areas where local traditions and practices align with formal standards, as well as those that require further improvement or innovation.
This point becomes apparent when analyzing the case; the real patients have the surgery under such guidelines, and in the local healthcare field, there are some special characteristics. Therefore, we compare the local practices with both national and international standards to conduct a critical evaluation, enabling stakeholders to identify areas requiring major change and those adhering to established guidelines (Wongvibulsin et al., 2019, 12). By placing the appraisal into the caring environment feature, we can identify important contributors responsible for the processes and outcomes of care delivery.
Furthermore, the structure, mechanisms, and medication administration commonly encountered in CAD serve as the foundation for revealing the complex aspects of care delivery. With knowledge of the physicochemical aspects of CAD, clinicians can get a more precise and in-depth understanding of the exact path the disease takes, its progression, the prognostication, and the application of therapeutic interventions (Winter et al., 2022, 605). Therefore, in this case, medical professionals will appreciate the great opportunity to design care plans as a way of satisfying individual patients’ needs, most especially their unique clinical profiles, and increasing treatment efficacy as well as the patients’ outcomes.
Additionally, the adoption of a patient-centered approach to disease care necessitates the integration of principles of ethics and multidisciplinary viewpoints into the screening mechanism (Eberly et al., 2020, 511). Given the multifaceted scope of healthcare delivery, managing ethical dilemmas, safeguarding patients’ autonomy, and enhancing collaborative approaches between different specialties are all relevant issues to be addressed (Ullah et al., 2023, 101). Through dealing with these ethical and multi-faceted aspects, assessment becomes more than just clinical efficacy; it also includes medical ethics, patient-centered care, and a shared decision-making process (Tripathi et al., 2021, 1395). We can look at CAD care in our area from different angles by combining anatomical, pathophysiological, pharmacological, bioethical, and interdisciplinary points of view. This gives the content more depth and breadth and lets us do a thorough analysis.
We rigorously planned and used an extensive article search strategy with the help of PubMed, Embase, and the Cochrane Library to conduct a solid evaluation. We selected cardiac disease-related keywords such as “coronary artery disease,” “cardiovascular care,” “guidelines,” and “interventions” to search for long-term research relevant to the local practice evaluation (Treskes et al., 2021, 119). On the one hand, this systematic approach expanded the domain of observable data; on the other hand, it greatly contributed to a more fine-tuned understanding of how the flow of cardiovascular support services progressed.
From the interpreted literature, the critical appraisal of research articles turned out to be a key aspect of this dissertation in building the credibility and validity of the evaluation procedures. The screening of applicable research studies and the application of the highest evaluation standards reveal a sustainable methodological strength, enabling the application of the findings to the facility’s care context (Treskes et al., 2021, 119). For instance, qualitative inquiries carry out crucial research at the level of patients experiencing cardiovascular disorders, thereby enhancing their subjective perspectives, needs, and challenges. Conversely, quantitative studies play a crucial role in providing statistical significance to the proposed interventions, thereby facilitating decision-making and serving as a guide for designing patient-specific care plans (Tekkeşin et al., 2021, 25). An insightful combination of qualitative and quantitative research approaches ensures this analysis, providing tools to fully exploit the abundant realm of evidence and shape policy-driven recommendations aimed at improving the quality of cardiovascular care.
In addition to the globally acknowledged established classic risk factors for CAD, recent research has revealed the importance of new risk factors like psychosocial stress, air pollution, and sleep disorders. Understanding the complex interrelationship between these determinants and how to cope with their effects is pivotal for the development of successful strategies to prevent such problems (Semb et al., 2020, 370). Initiatives at the community level would need to aim at a comprehensive strategy, not only at individual-level risk factors but also at broader determinants of health. Furthermore, community-based programs that concentrate on encouraging healthy ways of living, including proper physical activity, balanced nutrition, and smoking cessation, are vital components in lowering the CA burden from the perspective of populations.
To top this off, those working on early prevention should also explore using technology and personalized medicine, which are at the forefront (Chen et al., 2019, 1006). Integration of genetic, environmental, and lifestyle factors on the basis of personal assessments of risk will help create more precise interventions that will be most efficient for certain individuals’ individual risk profiles. Last but not least, the application of targeted interventions based on genetic predispositions may present a hopeful direction for primary and secondary prevention, respectively (Sarraju et al., 2023, 843). Health professionals can allocate healthcare resources efficiently and improve patient outcomes by identifying patients at high risk of CAD based on their genetic information and tailoring interventions to their unique health situation.
Developing such assessments includes different modalities of diagnostics, such as stress testing, coronary angiography, and cardiac imaging techniques, to achieve accessibility and availability. This is fundamental for the timely assessment of CAD in the local healthcare setting (Sarraju et al., 2023, 843). However, it is crucial to assess these modalities beyond their mere presence, as factors such as the waiting period, geographical distribution, and affordability significantly impact patients’ choice of health service providers. Furthermore, we should prioritize the effectiveness of screening programs in early CAD detection, as the potential benefits of reducing the disease burden and improving outcomes are significant (Benjamin et al., 2019, 57). The barriers to screening programs, like reaching underserved communities and ensuring the follow-up care of those diagnosed with CAD, stress the urgent need for programs with novel strategies to believe in improved and optimal CAD management (Sandeep et al., 2023, 102). Experts have found that point-of-care testing in primary health care settings and community-based screening programs are the most effective avenues for promoting early illness detection and ultimately positive patient outcomes.
A multidisciplinary care team working with a disease-oriented approach is crucial for offering well-structured and patient-focused approaches to the management of coronary artery disease (CAD). The multidisciplinary teams, composed of different experts, including cardiologists, nurses, dietitians, and rehabilitation professionals, cover all the medical aspects and lifestyle interventions that provide the treatment for CAD (Sandeep et al., 2023, 102). A careful analysis of the effectiveness of the existing models of care is a matter of utmost relevance to determining the weak spots and ensuring appropriate treatment opportunities for all patients. Multidisciplinary teams improve coordination between their family members through developing joint care plans, arranging regular case conferences, and conducting telehealth consultations, which improve patient outcomes, streamline the process of care delivery, and contribute to the betterment of patient experiences with their healthcare services (Bays et al., 2021, 101).
Health-care-related policies and resource allocation are the central factors that determine whether cardiovascular care will be of high quality and easy to get. Dropping funding or resources in this manner directly reduces the number of condition-essential services, diagnostic tools, and treatments available to people with cardiovascular diseases (Bayoumy et al., 2021, 582). Despite this, there is often a significant disparity in access to care due to socioeconomic conditions and geographical factors, making it challenging to eliminate these gaps (Quer et al., 2021, 310). Assessing the current policies and funding mechanisms is a fundamental step in resolving these difficulties, as it can identify the structural barriers that prevent the provision of care for the disadvantaged. Healthcare systems can reduce disparities and improve cardiovascular health outcomes for society by advocating policies that emphasize equitable resource distributions and provide dedicated services to those left behind.
Moreover, efforts to establish health equity in the distribution of cardiovascular care should extend beyond policy changes to include community-based activities and collaboration. Efforts from multiple partners, including healthcare providers, community organizations, and political players, are critical, as comprehensive measures that tackle the heart of healthcare disparities and program sustainability are required (Narimanovna, 2023, 1003). If a person develops an approach that marks fairness and supports the pressing needs of vulnerable segments of society, there will be the possibility of increasing awareness of preventive services, early detection of cardiovascular disorders, and effective management of the diseases. By using the resources and solutions that can be tailored to the needs of each patient, policymakers could be a real force behind the development of health equity and the improvement of cardiovascular health in each community, no matter how diverse their cultural and socioeconomic backgrounds are (Arenas de Larriva et al., 2020, 3219).
Patient education on CAD stands at the base of successful treatment provision and makes patients co-authors of their recovery and prophylaxis. One of the main roles of health professionals is to educate the public about factors such as disease causes, risk factors, lifestyle changes, and treatment options, which help individuals make decisions that can promote their health. However, we must rigorously evaluate the efficacy and availability of current educational tools to ensure they effectively address the needs of individuals with CAD (Andgi, 2019, 87). New models, including digital health instruments that may range from mobile applications to wearables, gamification strategies to change behavior, and volunteer networks aimed at patient support, will change patient education and boost patient involvement in self-care activities.
In addition, the employment of these innovative techniques not only helps in the process of knowledge acquisition but also imparts a feeling of empowerment and responsibility for their own health status among the CAD patients. Through technology utilization and social network forging, healthcare providers will construct interactive and personal learning experiences for each subject, adaptable to the unique needs and learning speeds (Moshawrab et al., 2023, 828). Changes in medical educational programs and practices over time can result in the empowerment of CAD patients and let them take a major part in disease management. The following results in improved adherence to the treatment, health outcomes, and human quality of life.
Among the latest breakthroughs in the area of cardiovascular medicine, there are new therapeutic approaches to coronary artery disease (CAD). A different line of research with great possibilities is gene therapy, stem cell therapy, and targeted drug delivery systems. Gene therapy offers the advantage of correcting at the genetic level, bypassing the genetic factors that cause CAD (Moses et al., 2022, 51). Gene therapy for cardiovascular diseases aims to deliver therapeutic genes to diseased endothelial cells, intervening in cellular functions, promoting vasculogenesis, and halting the formation of atherosclerotic plaque. Stem cell therapy has shown great potential in regenerating the myocardium and reallocating damaged cardiac function. This type of treatment involves taking stem cells from the patient or a donor and putting them into the myocardium (Jafaripour et al., 2019, 29). The goal is to help functional structures like capillaries and cardiomyocytes form, which may improve the heart muscle’s ability to contract and receive blood.
On the other hand, the transfer of these inventive therapeutic strategies from the laboratory to the patient has numerous challenges and requires thoughtful analysis. As a new potential, although limited and challenging, gene therapy and stem cell therapy can form the basis of CAD management in the future. Investigating vector-mediated immune responses, off-target effects, and long-term safety issues is crucial before successfully introducing gene therapy into medicine (Moses et al., 2022, 51). Similarly, the successful transplantation of cells into the infarcted myocardium, a hostile microenvironment, poses challenges to their integration and proper survival. On the contrary, ethical problems related to the use of embryonic stem cells and the possibility of the development of tumorigenicity demand deep reflection and caution (Hussain et al., 2019, 588). In spite of the problems that stand in the way, the fact that more clinical trials and continued translational research work are going on indicates a glimmer of hope that it is possible that these novel therapeutic interventions will be fine-tuned and eventually be better implemented for cardiovascular care.
Proposing innovative approaches to enhance care delivery for CAD patients entails a multifaceted strategy that addresses various dimensions of patient care. Firstly, the implementation of personalized care plans, tailored to individual patient needs and risk profiles, emerges as a cornerstone of effective intervention. By leveraging risk stratification tools, healthcare providers can accurately assess patients’ susceptibility to adverse cardiac events and devise targeted interventions to mitigate risks proactively (Lloyd-Jones et al., 2019, 30). Moreover, integrating technology for remote monitoring presents a promising avenue for enhancing patient engagement and facilitating real-time data collection. Through wearable devices and telemedicine platforms, healthcare teams can monitor patients’ vital signs, medication adherence, and symptom progression remotely, enabling timely interventions and reducing the burden of frequent hospital visits.
Additionally, enhancing patient education and self-management programs constitutes a fundamental aspect of improving CAD care delivery. Empowering patients with comprehensive knowledge about their condition, treatment options, and lifestyle modifications fosters informed decision-making and a sense of ownership over their health. By equipping patients with the necessary skills and resources to manage their condition effectively, healthcare providers can promote adherence to treatment regimens and facilitate positive health behaviors, ultimately leading to improved clinical outcomes and enhanced quality of life (Keteyian et al., 2020, 8). Explicit reflection on the findings and insights garnered from this evaluation is indispensable for driving practice change. It necessitates a candid acknowledgment of existing gaps and deficiencies in current care delivery practices, coupled with a steadfast commitment to continuous professional development and the implementation of evidence-based interventions. By embracing a culture of reflective practice and ongoing learning, healthcare providers can cultivate a dynamic and responsive healthcare environment that prioritizes patient-centered care and fosters innovation in cardiovascular disease management (Gyöngyösi et al., 2022, 3205).
In conclusion, through a comprehensive analysis of local care delivery to patients diagnosed with coronary artery disease (CAD), this essay has elucidated both the strengths and shortcomings inherent in current practices. We have identified key areas requiring enhancement, drawing upon evidence-based research and national guidelines, to propose innovative strategies. Addressing these deficiencies and embracing novel approaches presents a tangible opportunity to enhance the standard of care for individuals struggling with cardiovascular disease. Moreover, the implementation of tailored interventions holds promise for fostering improved clinical outcomes, bolstering patient well-being, and fostering a culture of continuous quality improvement within cardiovascular care settings. As such, this essay underscores the pivotal role of critical evaluation in driving meaningful advancements in care delivery, underscoring the imperative for ongoing reflection, adaptation, and innovation in the pursuit of optimal patient-centric outcomes.
Andgi, A., 2019. Peripheral Arterial Disease as a Predictor of Coronary Artery Disease in Type 2 Diabetes Mellitus Using Ankle Brachial Index (Doctoral dissertation, Rajiv Gandhi University of Health Sciences (India)).pp 45-98
Arenas de Larriva, A.P., Limia-Pérez, L., Alcalá-Díaz, J.F., Alonso, A., López-Miranda, J. and Delgado-Lista, J., 2020. Ceruloplasmin and coronary heart disease—a systematic review. Nutrients, 12(10), p.3219.
Bayoumy, K., Gaber, M., Elshafeey, A., Mhaimeed, O., Dineen, E.H., Marvel, F.A., Martin, S.S., Muse, E.D., Turakhia, M.P., Tarakji, K.G. and Elshazly, M.B., 2021. Smart wearable devices in cardiovascular care: where we are and how to move forward. Nature Reviews Cardiology, 18(8), pp.581-599.
Bays, H.E., Taub, P.R., Epstein, E., Michos, E.D., Ferraro, R.A., Bailey, A.L., Kelli, H.M., Ferdinand, K.C., Echols, M.R., Weintraub, H. and Bostrom, J., 2021. Ten things to know about ten cardiovascular disease risk factors. American journal of preventive cardiology, 5, p.100149.
Benjamin, E.J., Muntner, P., Alonso, A., Bittencourt, M.S., Callaway, C.W., Carson, A.P., Chamberlain, A.M., Chang, A.R., Cheng, S., Das, S.R. and Delling, F.N., 2019. Heart disease and stroke statistics—2019 update: a report from the American Heart Association. Circulation, 139(10), pp.e56-e528.
Chen, S., Zhu, J., Wang, M., Huang, Y., Qiu, Z., Li, J., Chen, X., Chen, H., Xu, M., Liu, J. and She, M., 2019. Comparison of the therapeutic effects of adipose‑derived and bone marrow mesenchymal stem cells on erectile dysfunction in diabetic rats. International Journal of Molecular Medicine, 44(3), pp.1006-1014.
Chui, K.T., Alhalabi, W., Pang, S.S.H., Pablos, P.O.D., Liu, R.W. and Zhao, M., 2020. Disease diagnosis in smart healthcare: Innovation, technologies and applications. Sustainability, 9(12), p.2309.
Eberly, L.A., Khatana, S.A.M., Nathan, A.S., Snider, C., Julien, H.M., Deleener, M.E. and Adusumalli, S., 2020. Telemedicine outpatient cardiovascular care during the COVID-19 pandemic: bridging or opening the digital divide?. Circulation, 142(5), pp.510-512.
Gyöngyösi, M., Pokushalov, E., Romanov, A., Perin, E., Hare, J.M., Kastrup, J., Fernández-Avilés, F., Sanz-Ruiz, R., Mathur, A., Wojakowski, W. and Martin-Rendon, E., 2022. Meta-analysis of percutaneous endomyocardial cell therapy in patients with ischemic heart failure by combination of individual patient data (IPD) of ACCRUE and publication-based aggregate data. Journal of clinical medicine, 11(11), p.3205.
Hussain, M.A., Colicchia, M., Veerapen, J., Weeraman, D., Podaru, M.N., Jones, D., Suzuki, K. and Mathur, A., 2019. Circulatory support and stem cell therapy in the management of advanced heart failure: a concise review of available evidence. Regenerative Medicine, 14(6), pp.585-593.
Jafaripour, S., Sasanejad, P., Dadgarmoghaddam, M. and Sadr-Nabavi, A., 2019. ADAMTS7 and ZC3HC1 share genetic predisposition to coronary artery disease and large artery ischemic stroke. Critical Reviews™ in Eukaryotic Gene Expression, 29(4).
Keteyian, S.J., Ades, P.A., Beatty, A.L., Gavic-Ott, A., Hines, S., Lui, K., Schopfer, D.W., Thomas, R.J. and Sperling, L.S., 2022. A review of the design and implementation of a hybrid cardiac rehabilitation program: an expanding opportunity for optimizing cardiovascular care. Journal of Cardiopulmonary Rehabilitation and Prevention, 42(1), pp.1-9.
Lloyd-Jones, D.M., Allen, N.B., Anderson, C.A., Black, T., Brewer, L.C., Foraker, R.E., Grandner, M.A., Lavretsky, H., Perak, A.M., Sharma, G. and Rosamond, W., 2019. Life’s essential 8: updating and enhancing the American Heart Association’s construct of cardiovascular health: a presidential advisory from the American Heart Association. Circulation, 146(5), pp.e18-e43.
Moses, J.C., Adibi, S., Angelova, M. and Islam, S.M.S., 2022. Smart home technology solutions for cardiovascular diseases: a systematic review. Applied System Innovation, 5(3), p.51.
Moshawrab, M., Adda, M., Bouzouane, A., Ibrahim, H. and Raad, A., 2023. Smart wearables for the detection of cardiovascular diseases: a systematic literature review. Sensors, 23(2), p.828.
Narimanovna, S.G., 2023. Features of Neuropsychological Disorders in Patients with Hemispheric Ischemic Stroke. AMALIY VA TIBBIYOT FANLARI ILMIY JURNALI, 2(12), pp.1002-1005.
Quer, G., Arnaout, R., Henne, M. and Arnaout, R., 2021. Machine learning and the future of cardiovascular care: JACC state-of-the-art review. Journal of the American College of Cardiology, 77(3), pp.300-313.
Sandeep, B., Wang, X. and Xiao, Z., 2023. Comment on: Smart Technologies used as Smart Tools in the Management of Cardiovascular Disease and their Future Perspective. Current Problems in Cardiology, p.102008.
Sarraju, A., Bruemmer, D., Van Iterson, E., Cho, L., Rodriguez, F. and Laffin, L., 2023. Appropriateness of cardiovascular disease prevention recommendations obtained from a popular online chat-based artificial intelligence model. Jama, 329(10), pp.842-844.
Semb, A.G., Ikdahl, E., Wibetoe, G., Crowson, C. and Rollefstad, S., 2020. Atherosclerotic cardiovascular disease prevention in rheumatoid arthritis. Nature Reviews Rheumatology, 16(7), pp.361-379.
Tekkeşin, A.İ., Hayıroğlu, M.İ., Çinier, G., Özdemir, Y.S., İnan, D., Yüksel, G., Pay, L., Parsova, K.E., Vatanoğlu, E.G., Şeker, M. and Durak, F., 2021. Lifestyle intervention using mobile technology and smart devices in patients with high cardiovascular risk: a pragmatic randomised clinical trial. Atherosclerosis, 319, pp.21-27.
Treskes, R.W., Van der Velde, E.T., Schoones, J.W. and Schalij, M.J., 2021. Implementation of smart technology to improve medication adherence in patients with cardiovascular disease: is it effective?. Expert review of medical devices, 15(2), pp.119-126.
Tripathi, A., Khan, M.S., Khan, A.R., Vaughn, V.M. and Bolli, R., 2021. Cell therapy for nonischemic dilated cardiomyopathy: A systematic review and meta-analysis of randomized controlled trials. Stem Cells Translational Medicine, 10(10), pp.1394-1405.
Ullah, M., Hamayun, S., Wahab, A., Khan, S.U., Rehman, M.U., Haq, Z.U., Rehman, K.U., Ullah, A., Mehreen, A., Awan, U.A. and Qayum, M., 2023. Smart technologies used as smart tools in the management of cardiovascular disease and their future perspective. Current Problems in Cardiology, 48(11), p.101922.
Winter, S.J., Sheats, J.L. and King, A.C., 2022. The use of behavior change techniques and theory in technologies for cardiovascular disease prevention and treatment in adults: a comprehensive review. Progress in cardiovascular diseases, 58(6), pp.605-612.
Wongvibulsin, S., Martin, S.S., Steinhubl, S.R. and Muse, E.D., 2019. Connected health technology for cardiovascular disease prevention and management. Current treatment options in cardiovascular medicine, 21, pp.1-15.
Wyckoff, M.H., Singletary, E.M., Soar, J., Olasveengen, T.M., Greif, R., Liley, H.G., Zideman, D., Bhanji, F., Andersen, L.W., Avis, S.R. and Aziz, K., 2022. 2021 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with treatment recommendations: summary from the basic life support; advanced life support; neonatal life support; education, implementation, and teams; first aid task forces; and the COVID-19 Working Group. Circulation, 145(9), pp.e645-e721.
Xu, Z., Neuber, S., Nazari-Shafti, T., Liu, Z., Dong, F. and Stamm, C., 2022. Impact of procedural variability and study design quality on the efficacy of cell-based therapies for heart failure-a meta-analysis. Plos one, 17(1), p.e0261462.
Zeymer, U., Bueno, H., Granger, C.B., Hochman, J., Huber, K., Lettino, M., Price, S., Schiele, F., Tubaro, M., Vranckx, P. and Zahger, D., 2020. Acute Cardiovascular Care Association position statement for the diagnosis and treatment of patients with acute myocardial infarction complicated by cardiogenic shock: A document of the Acute Cardiovascular Care Association of the European Society of Cardiology. European Heart Journal: Acute Cardiovascular Care, 9(2), pp.183-197.
Zhu, D. & Cheng, K., 2021. Cardiac cell therapy for heart repair: should the cells be left out?. Cells, 10(3), p.641.